HealthQuill
Pfizer Inc.’s sickle cell therapy involving Oxbryta has been voluntarily withdrawn from global markets due to painful complications and death, according to a company statement.
Drugs Health Pharma

Pfizer pulls out sickle cell therapy from global markets, cites death, snags

Pfizer Inc.’s sickle cell therapy involving Oxbryta has been voluntarily withdrawn from global markets due to painful complications and death, according to a.

Read More
Merck & Co., announced its trial drug along with a combination of the company’s Keytruda therapy failed to meet the main goal of overall survival in patients previously treated for a type of metastatic colorectal cancer. 
Drugs Health Pharma

Merck’s trial drug combination for colorectal cancer fails main goal

Merck & Co., announced its trial drug along with a combination of the company’s Keytruda therapy failed to meet the main goal of.

Read More
Amgen Inc.’s experimental drug to treat patients suffering from a rare muscle-weakening disease, myasthenia gravis, has shown positive results in an end-stage trial and the California-based company has started talks with regulators for its approval.
Drugs Health Pharma

Amgen’s trial drug to fight autoimmune disorder improves patient outcomes

Amgen Inc.’s experimental drug to treat patients suffering from a rare muscle-weakening disease, myasthenia gravis, has shown positive results in an end-stage trial.

Read More
IntraBio Inc, a biotechnology company focused on rare and neurodegenerative diseases, got the US regulator’s nod for a drug to treat a certain type of Niemann-Pick disease in adults and pediatric patients weighing about 15 kilograms.
Drugs Health Pharma

IntraBio Inc.’s drug for neurogenerative disorder gets US regulator’s nod

IntraBio Inc, a biotechnology company focused on rare and neurogenerative diseases, got the US regulator’s nod for a drug to treat a certain.

Read More
The European Union has announced a 1.23 billion euro initiative to prevent mental health issues and find affordable treatments for its 84 million patients in the bloc.
Drugs Health Pharma

Teva unveils insights on switching schizophrenia patients to Uzedy

September 24, 2024: Teva Pharmaceuticals presented new research demonstrating effective strategies for switching adult patients with schizophrenia from Perseris to Uzedy (risperidone extended-release.

Read More
The US national public agency has issued a Health Alert Network on the ongoing outbreak of the Clade I monkeypox virus, warning its nationals to avoid sex and proximity with an infected person.
Drugs Health Pharma

US agency’s health alert warns people of proximity with mpox-infected

The US national public agency has issued a Health Alert Network on the ongoing outbreak of the Clade I monkeypox virus, warning its.

Read More
About one in seven adolescents in the age group of 10-19 suffer from mental disorders such as depression and anxiety, according to the WHO.
Drugs Health Pharma

One in seven adolescents globally suffer from mental health disorders 

About one in seven adolescents in the age group of 10-19 suffer from mental disorders such as depression and anxiety, according to the.

Read More
"There is a fine line between genius and insanity" is often used to describe individuals who exhibit exceptional talent in various fields. Movies and popular media frequently reinforce this ‘mad genius’ stereotype.  It is an ascription of negative socioemotional characteristics, say a ‘quintessential teacher’s pet.’
Drugs Health Pharma

Opinion: I am a ‘mad genius,’ and I need academic, social support

"There is a fine line between genius and insanity" is often used to describe individuals who exhibit exceptional talent in various fields. Movies.

Read More
British-Swedish AstraZeneca and Japan's Daiichi Sankyo’s investigational drug for breast cancer failed to significantly improve the overall survival of the patients during an end-stage trial, according to a joint statement.
Drugs Health Pharma

AstraZeneca-Daiichi Sankyo’s breast cancer drug fails in late-stage trial

British-Swedish AstraZeneca and Japan's Daiichi Sankyo’s investigational drug for breast cancer failed to significantly improve the overall survival of the patients during an.

Read More
A new sensor technology designed and developed by professors and doctors at Cambridge University Hospitals may soon make hip surgery more precise and deliver better and long-lasting outcomes, according to a statement.
Drugs Medical Pharma

Cambridge develops precise sensors to aid hip replacement surgeries

A new sensor technology designed and developed by professors and doctors at Cambridge University Hospitals may soon make hip surgery more precise and.

Read More
X